🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Betelehem W. Yacob

Betelehem W. Yacob

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer”.

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer

Cancers(2020)10.3390/cancers12030719

N/A

0DataRank · unranked

24 citations

Dennis M. Simmons, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob, Brian Gittleman +7 more

RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer

BMC Cancer(2020)10.1186/s12885-020-07500-1

N/A

0DataRank · unranked

30 citations

Julie Lang, Anna Capasso, Deog Joong Kim, Ely Benaim, Young Bok Lee +10 more

Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0455

N/A

0DataRank · unranked

25 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. Phillips +15 more

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology(2021)10.3389/fonc.2021.642328

N/A

0DataRank · unranked

30 citations

Stacey M. Bagby, Betelehem W. Yacob, Dennis M. Simmons, Morgan MacBeth, Christopher H. Lieu +8 more

Data from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

(2023)10.1158/1535-7163.c.6543273.v1

N/A

0DataRank · unranked

0 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. K. Phillips +15 more

Data from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

(2023)10.1158/1535-7163.c.6543273

N/A

0DataRank · unranked

0 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. K. Phillips +15 more

Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling

International Journal of Cancer(2024)10.1002/ijc.35087

N/A

0DataRank · unranked

5 citations

Robert J. Van Gulick, William A. Robinson, Tariq I. Mughal, Richard P. Tobin, Morgan MacBeth +22 more

Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)

PLoS ONE(2024)10.1371/journal.pone.0298808

N/A

0DataRank · unranked

8 citations

Betelehem W. Yacob, Monica E. Brown, Brandon R. Goldstein, John J. Arcaroli, Stacey M. Bagby +11 more